Cyamemazine

DB09000

small molecule experimental

Deskripsi

Cyamemazine (Tercian), also known as cyamepromazine, is a typical antipsychotic drug of the phenothiazine class used primarily in the treatment of schizophrenia and psychosis-associated anxiety. Cyamemazine actually behaves like an atypical antipsychotic, due to its potent anxiolytic effects (5-HT2C) and lack of extrapyramidal side effects (5-HT2A).

Struktur Molekul 2D

Berat 323.455
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

829 Data
Buprenorphine Cyamemazine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Cyamemazine.
Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Cyamemazine.
Droperidol Droperidol may increase the central nervous system depressant (CNS depressant) activities of Cyamemazine.
Hydrocodone Cyamemazine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Cyamemazine.
Magnesium sulfate The therapeutic efficacy of Cyamemazine can be increased when used in combination with Magnesium sulfate.
Methotrimeprazine Cyamemazine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Cyamemazine.
Mirtazapine Cyamemazine may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Cyamemazine.
Orphenadrine Cyamemazine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Paraldehyde Cyamemazine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Cyamemazine.
Pramipexole Cyamemazine may increase the sedative activities of Pramipexole.
Ropinirole Cyamemazine may increase the sedative activities of Ropinirole.
Rotigotine Cyamemazine may increase the sedative activities of Rotigotine.
Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Cyamemazine.
Sodium oxybate Cyamemazine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.
Suvorexant Cyamemazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Cyamemazine.
Thalidomide Cyamemazine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Zolpidem Cyamemazine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Yohimbine The therapeutic efficacy of Cyamemazine can be increased when used in combination with Yohimbine.
Porfimer sodium Cyamemazine may increase the photosensitizing activities of Porfimer sodium.
Verteporfin Cyamemazine may increase the photosensitizing activities of Verteporfin.
Amisulpride Cyamemazine may increase the antipsychotic activities of Amisulpride.
Methylphenidate The risk or severity of adverse effects can be increased when Cyamemazine is combined with Methylphenidate.
Dexmethylphenidate The risk or severity of adverse effects can be increased when Cyamemazine is combined with Dexmethylphenidate.
Metoclopramide The risk or severity of adverse effects can be increased when Metoclopramide is combined with Cyamemazine.
Quinagolide The therapeutic efficacy of Quinagolide can be decreased when used in combination with Cyamemazine.
Sulpiride Cyamemazine may increase the antipsychotic activities of Sulpiride.
Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Cyamemazine.
Lithium citrate Lithium citrate may increase the neurotoxic activities of Cyamemazine.
Lithium hydroxide Lithium hydroxide may increase the neurotoxic activities of Cyamemazine.
Mequitazine Cyamemazine may increase the arrhythmogenic activities of Mequitazine.
Tetrabenazine The risk or severity of adverse effects can be increased when Cyamemazine is combined with Tetrabenazine.
Deutetrabenazine The risk or severity of adverse effects can be increased when Cyamemazine is combined with Deutetrabenazine.
Thiopental The risk or severity of adverse effects can be increased when Cyamemazine is combined with Thiopental.
Metyrosine The risk or severity of extrapyramidal symptoms and CNS depression can be increased when Metyrosine is combined with Cyamemazine.
Ethanol Cyamemazine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Azelastine Cyamemazine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Brimonidine Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Cyamemazine.
Fluvoxamine The risk or severity of adverse effects can be increased when Cyamemazine is combined with Fluvoxamine.
Citalopram The risk or severity of adverse effects can be increased when Cyamemazine is combined with Citalopram.
Duloxetine The risk or severity of adverse effects can be increased when Cyamemazine is combined with Duloxetine.
Trazodone The risk or severity of adverse effects can be increased when Cyamemazine is combined with Trazodone.
Paroxetine The risk or severity of adverse effects can be increased when Cyamemazine is combined with Paroxetine.
Sertraline The risk or severity of adverse effects can be increased when Cyamemazine is combined with Sertraline.
Sibutramine The risk or severity of adverse effects can be increased when Cyamemazine is combined with Sibutramine.
Nefazodone The risk or severity of adverse effects can be increased when Cyamemazine is combined with Nefazodone.
Escitalopram The risk or severity of adverse effects can be increased when Cyamemazine is combined with Escitalopram.
Zimelidine The risk or severity of adverse effects can be increased when Cyamemazine is combined with Zimelidine.
Dapoxetine The risk or severity of adverse effects can be increased when Cyamemazine is combined with Dapoxetine.
Milnacipran The risk or severity of adverse effects can be increased when Cyamemazine is combined with Milnacipran.
Desvenlafaxine The risk or severity of adverse effects can be increased when Cyamemazine is combined with Desvenlafaxine.
Seproxetine The risk or severity of adverse effects can be increased when Cyamemazine is combined with Seproxetine.
Levomilnacipran The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Cyamemazine.
Indalpine The risk or severity of adverse effects can be increased when Cyamemazine is combined with Indalpine.
Ritanserin The risk or severity of adverse effects can be increased when Cyamemazine is combined with Ritanserin.
Alaproclate The risk or severity of adverse effects can be increased when Cyamemazine is combined with Alaproclate.
Esmolol The serum concentration of Esmolol can be increased when it is combined with Cyamemazine.
Betaxolol The serum concentration of Betaxolol can be increased when it is combined with Cyamemazine.
Metoprolol The serum concentration of Metoprolol can be increased when it is combined with Cyamemazine.
Atenolol The serum concentration of Atenolol can be increased when it is combined with Cyamemazine.
Timolol The serum concentration of Timolol can be increased when it is combined with Cyamemazine.
Sotalol The serum concentration of Sotalol can be increased when it is combined with Cyamemazine.
Propranolol The serum concentration of Propranolol can be increased when it is combined with Cyamemazine.
Labetalol The serum concentration of Labetalol can be increased when it is combined with Cyamemazine.
Bisoprolol The serum concentration of Bisoprolol can be increased when it is combined with Cyamemazine.
Alprenolol The serum concentration of Alprenolol can be increased when it is combined with Cyamemazine.
Pindolol The serum concentration of Pindolol can be increased when it is combined with Cyamemazine.
Carvedilol The serum concentration of Carvedilol can be increased when it is combined with Cyamemazine.
Propafenone The serum concentration of Propafenone can be increased when it is combined with Cyamemazine.
Acebutolol The serum concentration of Acebutolol can be increased when it is combined with Cyamemazine.
Nadolol The serum concentration of Nadolol can be increased when it is combined with Cyamemazine.
Bevantolol The serum concentration of Bevantolol can be increased when it is combined with Cyamemazine.
Practolol The serum concentration of Practolol can be increased when it is combined with Cyamemazine.
Penbutolol The serum concentration of Penbutolol can be increased when it is combined with Cyamemazine.
Oxprenolol The serum concentration of Oxprenolol can be increased when it is combined with Cyamemazine.
Dexpropranolol The serum concentration of Dexpropranolol can be increased when it is combined with Cyamemazine.
Celiprolol The serum concentration of Celiprolol can be increased when it is combined with Cyamemazine.
Nebivolol The serum concentration of Nebivolol can be increased when it is combined with Cyamemazine.
Bufuralol The serum concentration of Bufuralol can be increased when it is combined with Cyamemazine.
Bopindolol The serum concentration of Bopindolol can be increased when it is combined with Cyamemazine.
Bupranolol The serum concentration of Bupranolol can be increased when it is combined with Cyamemazine.
Indenolol The serum concentration of Indenolol can be increased when it is combined with Cyamemazine.
Arotinolol The serum concentration of Arotinolol can be increased when it is combined with Cyamemazine.
Levobetaxolol The serum concentration of Levobetaxolol can be increased when it is combined with Cyamemazine.
Talinolol The serum concentration of Talinolol can be increased when it is combined with Cyamemazine.
Anisodamine The serum concentration of Anisodamine can be increased when it is combined with Cyamemazine.
Bucindolol The serum concentration of Bucindolol can be increased when it is combined with Cyamemazine.
Esatenolol The serum concentration of Esatenolol can be increased when it is combined with Cyamemazine.
Cloranolol The serum concentration of Cloranolol can be increased when it is combined with Cyamemazine.
Mepindolol The serum concentration of Mepindolol can be increased when it is combined with Cyamemazine.
Epanolol The serum concentration of Epanolol can be increased when it is combined with Cyamemazine.
Tertatolol The serum concentration of Tertatolol can be increased when it is combined with Cyamemazine.
Landiolol The serum concentration of Landiolol can be increased when it is combined with Cyamemazine.
Morphine The risk or severity of hypotension and CNS depression can be increased when Cyamemazine is combined with Morphine.
Codeine The risk or severity of hypotension and CNS depression can be increased when Cyamemazine is combined with Codeine.

Target Protein

5-hydroxytryptamine receptor 2A HTR2A
5-hydroxytryptamine receptor 1A HTR1A
5-hydroxytryptamine receptor 7 HTR7
5-hydroxytryptamine receptor 2C HTR2C

Referensi & Sumber

Synthesis reference: U.S. Patent 2,877,224.

Contoh Produk & Brand

Produk: 0 • International brands: 1
International Brands
  • Tercian — Sanofi-Aventis

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul